These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19825898)

  • 1. Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.
    Le Melledo JM; Perez-Parada J; Morrow J; Bellavance F; Lara N; Jahandar F; Granger R; Tait G; McManus K
    J Psychopharmacol; 2011 Jan; 25(1):71-7. PubMed ID: 19825898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ethinyl estradiol on the panic response to the panicogenic agent pentagastrin.
    McManus K; Tait GR; Bellavance F; Le Mellédo JM
    J Affect Disord; 2001 Oct; 66(2-3):273-9. PubMed ID: 11578682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.
    Morrow JD; McManus K; Tait GR; Bellavance F; Chrapko W; Lara N; Le Mellédo JM
    J Psychiatry Neurosci; 2003 Mar; 28(2):127-33. PubMed ID: 12670129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin.
    Tait GR; McManus K; Bellavance F; Lara N; Chrapko W; Le Mellédo JM
    Psychoneuroendocrinology; 2002 May; 27(4):417-29. PubMed ID: 11911996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
    McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW
    Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers.
    Zedkova L; Coupland NJ; Man GC; Dinsa G; Sanghera G
    Depress Anxiety; 2003; 17(2):78-87. PubMed ID: 12621596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study.
    Coupland N; Zedkova L; Sanghera G; Leyton M; Le Mellédo JM
    J Psychiatry Neurosci; 2001 May; 26(3):247-51. PubMed ID: 11394194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder.
    Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N
    Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J; Koszycki D; Paradis M; Reece P; Hinton J; Sedman A
    Biol Psychiatry; 1995 Dec; 38(11):742-6. PubMed ID: 8580227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.
    McCann UD; Morgan CM; Geraci M; Slate SO; Murphy DL; Post RM
    Neuropsychopharmacology; 1997 Dec; 17(6):360-9. PubMed ID: 9397424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E; Tõru I; Vasar V; Shlik J
    J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
    Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
    J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacks.
    Lara N; Chrapko WE; Archer SL; Bellavance F; Mayers I; Le Mellédo JM
    Neuropsychopharmacology; 2003 Oct; 28(10):1840-5. PubMed ID: 12865901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed increase in LDL cholesterol following pentagastrin-induced panic attacks.
    Perez-Parada J; Jhangri GS; Lara N; Chrapko W; Castillo Abadia Mdel P; Gil L; Le Mellédo JM
    Psychopharmacology (Berl); 2007 Aug; 193(3):333-40. PubMed ID: 17450352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentagastrin has panic-inducing properties in obsessive compulsive disorder.
    de Leeuw AS; Den Boer JA; Slaap BR; Westenberg HG
    Psychopharmacology (Berl); 1996 Aug; 126(4):339-44. PubMed ID: 8878350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
    van Megen HJ; Westenberg HG; den Boer JA; Haigh JR; Traub M
    Psychopharmacology (Berl); 1994 Apr; 114(3):449-55. PubMed ID: 7855203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls.
    van Vliet IM; Westenberg HG; Slaap BR; den Boer JA; Ho Pian KL
    Biol Psychiatry; 1997 Jul; 42(1):76-8. PubMed ID: 9193745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.